FDA Import Refusal AEK-7751616-6/11/1 — Novo Nordisk Inc.
The FDA refused shipment AEK-7751616-6/11/1 from Novo Nordisk Inc. (United States) on Aug 25, 2020. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 25, 2020
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75